Opzelura Experience Study

Atopic dermatitis is a common multifactorial skin disease. Topicals are the mainstay of treatment, but adherence to topicals is often abysmal, possibly worsened by the complexity of recommended treatment algorithms. Giving patients a simple, one drug approach may be advantageous.

Inclusion Criteria: * Patients ≥2 years of age * Patients with a current diagnosis of atopic dermatitis that is mild-to-moderate in severity and in ≥2 body areas * Patients with up to 20% total body surface area involvement * Women of childbearing age taking/using a contraceptive Exclusion Criteria: * Patients without a current diagnosis of atopic dermatitis * Patients who are prescribed changing systemic medications or treatments (phototherapy, biologics) for atopic dermatitis * Patients who would require use of other topical medications for other diagnoses (tretinoin, clindamycin) * Patients with areas of skin with active infection * Patients who are pregnant